Skip to main content
Johnson & Johnson
Healthcare · Drug Manufacturers - General
Made on Jun 23, 2026
Price at call $231.29
6-month call Neutral +1.2%
Target by Dec 2026 $234.04
Great value below $190.00
Model v0.3.0

Projection vs Actual (6M history + forecast)

Our straight 6-month prediction (bold) with a textured realism line, and the actual price overlaid from the prediction date forward.

Forecast

One directional 6-month call and the six monthly points we'll be scored against. Predicted Jun 23, 2026 3:11 am
Neutral JNJ trends range-bound to $234.04 (+1.2% from $231.29) by Dec 2026.
Monthmonths after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $231.29 at call
Prediction made Jun 23, 2026 $231.29 at call
M1 Jul 23, 2026 $231.75 +0.2%
What actually happened: closed $255.63 on Jul 22, 2026 = +10.5% vs the call (predicted +0.2%)  ·  direction MISS (called flat, was up)  ·  off by 10.3 pp  ·  accuracy 4/10  ·  S&P +1.8% over the same window — lagged it
M2 Aug 23, 2026 $232.21 +0.4%
What actually happened: closed $270.24 on Aug 21, 2026 = +16.8% vs the call (predicted +0.4%)  ·  direction MISS (called flat, was up)  ·  off by 16.4 pp  ·  accuracy 4/10  ·  S&P +4.2% over the same window — lagged it
M3 Sep 23, 2026 $232.67 +0.6%
M4 Oct 23, 2026 $233.13 +0.8%
M5 Nov 23, 2026 $233.58 +1.0%
M6 Dec 23, 2026 $234.04 +1.2%

Deserved value (DCF/composite) is $245.68; over 6 months we project closing only part-way to it (reach 19.1%). Value-only — see Not Yet Modeled below.

Weaknesses

No weaknesses recorded for this run.

All inputs present, no fallbacks used — nothing to flag.

Equation Inputs

Everything feeding the v0.3.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$231.29
Composite fair value$193.25
Signal-adjusted fair value$185.90
DCF fair value$225.29
Anchored-PE fair value$214.03
Buy-below (value lens)$190.00
Value net score-77
Value confidence7 / 10
Quality net score+87
Memo confidence8 / 10
Deserved value (base)$209.27
Quality tilt+17.4%
Deserved value (used)$245.68
Coherence (value × quality)0.50

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 21.9%  3m 18.8%  6m 17.4%  
Daily σ (realism noise)1.2%
Beta vs S&P 500 1m -0.64  3m -0.08  5m -0.07  
Trailing 6-month return10.0%

Knobs (equation params)

Deserved wt · DCF0.5
Quality tilt cap (±)0.2
Horizon reach (6mo)0.45
Coherence floor (conflict)0.5
Conviction gain / pt0.06
Realism mean-reversion φ0.85
Conviction floor0.4
Deserved wt · composite0.5
Realism vol window3m
Neutral band (%)5
Horizon (months)6
Realism σ fallback0.015

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.3.0 #6bd904191719

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jun 23, 2026 freshest JNJ-20260623-030002-c100
ext-forensic-memo Jun 23, 2026 freshest ext-JNJ-20260623-030949-cad8
ext-lens-quality Jun 23, 2026 freshest ext-JNJ-20260623-030949-cad8
ext-lens-value Jun 23, 2026 freshest ext-JNJ-20260623-030949-cad8
scenario-valuation Jun 23, 2026 freshest JNJ-20260623-030002-c100
valuation-synthesis Jun 23, 2026 freshest JNJ-20260623-030002-c100

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Jul 30, 2026 v0.6.0 Neutral $265.53 $254.00 -4.3% Jan 2027 view
Jun 23, 2026 v0.3.0 Neutral $231.29 $234.04 +1.2% Dec 2026 viewing

Not Yet Modeled

What this v0.3.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Signal-adjusted fair value ($185.9) — the red-flag-adjusted anchor isn't the primary input yet (we use the raw DCF/composite blend, which double-counts DCF).
  • Recent momentum / drift — the line takes off straight; the trailing 6-month move (10%) doesn't bend the slope.
  • Market beta — computed (1–5mo) for context but does not condition the path.
  • Earnings dates, catalysts, and known events — not modeled.
  • Macro regime & sector rotation — not modeled.
  • Horizon is a fixed 6-month assumption, not a modeled time-to-target.
  • Outcome scoring — predictions aren't yet graded against realized price once the evaluation date passes.